News
Advertisement
The award honors an APSHO member who demonstrates exemplary leadership and makes outstanding contributions.
Erin M. Pierce, MSN, APRN, FNP-C, discusses key takeaways and shares insights from the workshop at JADPRO Live.
Research presented at JADPRO Live 2024 illuminated the diagnostic experiences of patients with colorectal cancer.
The workshop provided education and resources on providing cancer care for adolescents and young adults.
Researchers presented the results of the intervention program at JADPRO Live, the Annual APSHO Meeting.
Hear expert insights on how APPs can play a key role in expanding access to clinical trials and promoting diversity.
Theresa Wicklin Gillespie, PhD, MA, RN, FAAN, discusses her workshop on improving clinical trial representation and access.
New research shows that quitting smoking after a cancer diagnosis can meaningfully improve survival outcomes.
The study explores the effects of a Saturday pap smear clinic on improving access to cervical cancer screening for women.
National Nurse Practitioner Week is taking place from November 10-16 this year.
An expert shares her insights on how nurses can facilitate empathetic, respectful care and communication for veterans.
Susan K. Lee, PhD, MSN, RN, CNE, CPXP, FAAN, discusses her lifelong advocacy for veterans and the inspiration behind it.
TROPiCS-02 study data shows that sacituzumab govitecan improves overall survival for HR+/HER2- metastatic breast cancer.
As we observe Veterans Day this month, it's critical to remember that military service is a key patient assessment point.
The study analyzed how decision making and quality of life contribute to treatment regret in patients with prostate cancer.
New research and therapeutic approaches are challenging long-held beliefs about this type of graft.
As a nonpharmacological intervention with high acceptability and enjoyment, virtual reality may be an effective strategy.
In addition to knowing what herbal products patients take, it’s equally as important to understand why they take them.
Understanding critical symptoms in the “CRAB” acronym can enable oncology nurses to educate patients and caregivers.
The FDA also approved the VENTANA CLDN18 RxDx Assay as a companion diagnostic device.
Advertisement
630 Madison Ave.
Manalapan, NJ 07726
© 2024 Mashup Media, LLC, a Formedics Property. All Rights Reserved.